Dr BENGRINE-LEFEVRE Leila

Fiche personne


coordonnées

Centre Georges-François Leclerc
1 rue Professeur Marion
BP 77 980
21079 DIJON Cedex

03 80 73 75 28

Territoire

Bourgogne

Statut

Hospitalier

Recherche

Expertises :
- Clinique:Oncologie Médicale
- Clinique:Gériatrie

Publications


Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial.

Ray-Coquard IL, Savoye AM, Schiffler C, Mouret-Reynier MA, Derbel O, Kalbacher E, LeHeurteur M, Martinez A, Cornila C, Martinez M, Bengrine Lefevre L, Priou F, Cloarec N, Venat L, Selle F, Berton D, Collard O, Coquan E, Le Saux O, Treilleux I, Gouerant S, Angelergues A, Joly F, Tredan O

Nat Commun. 2024 07 16;15(1):5931

Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASE.

Buchalet C, Lemanski C, Pommier P, Le Malicot K, Bonichon-Lamichhane N, Evesque L, Diaz O, Ronchin P, Quero L, Campo ERD, Tougeron D, Salas S, Bengrine-Lefevre L, Lepage C, Vendrely V

Dig Liver Dis. 2024 07 12;:

Improving olaparib exposure to optimize adverse effects management.

Sterlé M, Puszkiel A, Burlot C, Pereira E, Bellesoeur A, De Percin S, Beinse G, Fumet JD, Favier L, Niogret J, Blanchet B, Royer B, Bengrine-Lefevre L, Schmitt A

Ther Adv Med Oncol. 2024 04 24;16:17588359241248328

Voir plus